Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Barry Uretsky

Concepts (770)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Percutaneous Coronary Intervention
97
2024
328
21.440
Why?
Coronary Occlusion
58
2023
80
12.410
Why?
Coronary Artery Disease
41
2024
317
12.010
Why?
Fractional Flow Reserve, Myocardial
39
2023
127
11.160
Why?
Angioplasty, Balloon, Coronary
55
2020
175
10.460
Why?
Coronary Angiography
114
2023
384
8.430
Why?
Stents
54
2023
372
8.370
Why?
Coronary Vessels
37
2024
172
7.470
Why?
Coronary Stenosis
22
2021
98
6.050
Why?
Myocardial Infarction
52
2024
445
5.060
Why?
Drug-Eluting Stents
22
2023
101
4.740
Why?
Treatment Outcome
128
2024
5456
4.480
Why?
Cardiac Catheterization
33
2023
241
3.900
Why?
Coronary Artery Bypass
19
2022
136
2.950
Why?
Humans
324
2024
52114
2.830
Why?
Heart Failure
53
2021
565
2.820
Why?
Acute Coronary Syndrome
8
2022
106
2.700
Why?
Chronic Disease
55
2023
585
2.350
Why?
Tomography, Optical Coherence
8
2018
108
2.220
Why?
Coronary Disease
26
2015
164
2.140
Why?
Saphenous Vein
14
2021
65
2.140
Why?
Risk Factors
76
2023
3922
2.050
Why?
Graft Occlusion, Vascular
13
2021
78
2.030
Why?
Platelet Aggregation Inhibitors
12
2014
211
1.980
Why?
Coronary Thrombosis
9
2020
23
1.980
Why?
Male
186
2024
26652
1.900
Why?
Myocardial Ischemia
13
2020
132
1.740
Why?
Predictive Value of Tests
27
2023
939
1.710
Why?
Cardiology
14
2019
101
1.710
Why?
Aged
103
2023
10142
1.680
Why?
Registries
33
2023
629
1.670
Why?
Middle Aged
141
2024
13028
1.660
Why?
Thrombosis
11
2018
252
1.640
Why?
Coronary Restenosis
8
2021
39
1.610
Why?
Myocardium
20
2013
477
1.540
Why?
Time Factors
53
2023
2970
1.540
Why?
Heptanoic Acids
15
2008
35
1.470
Why?
Pyrroles
15
2008
72
1.440
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
13
2022
147
1.370
Why?
Risk Assessment
30
2023
1339
1.350
Why?
Heart Injuries
3
2019
16
1.310
Why?
Female
140
2024
28055
1.290
Why?
Cardiac Tamponade
4
2024
29
1.230
Why?
Cardiotonic Agents
23
2019
85
1.220
Why?
Ventricular Function, Left
16
2023
177
1.220
Why?
Myocardial Reperfusion Injury
10
2011
53
1.170
Why?
Postoperative Complications
17
2019
1071
1.100
Why?
Hemodynamics
38
2018
264
1.100
Why?
Collateral Circulation
10
2020
38
1.090
Why?
Vasodilator Agents
8
2016
93
1.060
Why?
Coronary Circulation
11
2024
57
1.010
Why?
Societies, Medical
10
2019
200
1.000
Why?
Heart-Assist Devices
4
2020
154
0.990
Why?
Heart Transplantation
28
2009
341
0.970
Why?
Contrast Media
9
2018
173
0.950
Why?
Ventricular Dysfunction, Left
8
2018
108
0.920
Why?
Prosthesis Design
11
2021
260
0.920
Why?
Cardiac Catheters
4
2020
12
0.920
Why?
Thrombolytic Therapy
2
2020
113
0.910
Why?
Death, Sudden, Cardiac
6
2008
59
0.870
Why?
Pericarditis
2
2022
20
0.870
Why?
Balloon Occlusion
1
2024
17
0.840
Why?
Adenosine
7
2018
72
0.840
Why?
Algorithms
6
2021
663
0.840
Why?
Pericardial Effusion
1
2024
39
0.830
Why?
Hemorrhage
4
2019
222
0.810
Why?
Digitalis
2
2021
5
0.810
Why?
Cardiovascular Agents
5
2009
65
0.790
Why?
Occupational Health
1
2023
66
0.780
Why?
Aneurysm, False
5
2020
43
0.780
Why?
Pericarditis, Constrictive
1
2022
2
0.780
Why?
Aorta
4
2019
170
0.750
Why?
Retrospective Studies
31
2020
6610
0.730
Why?
Hypotension, Controlled
1
2021
3
0.730
Why?
Radiography, Interventional
7
2018
58
0.730
Why?
Anemia
1
2022
75
0.710
Why?
Angina, Unstable
8
2016
30
0.700
Why?
Thrombocytopenia
1
2022
93
0.690
Why?
Mammary Arteries
3
2017
10
0.690
Why?
Absorbable Implants
2
2022
13
0.690
Why?
Follow-Up Studies
27
2019
2282
0.690
Why?
Prognosis
19
2023
2093
0.680
Why?
Inferior Wall Myocardial Infarction
1
2020
1
0.670
Why?
Thiazolidinediones
6
2008
81
0.660
Why?
Time-to-Treatment
2
2020
77
0.650
Why?
Shock, Cardiogenic
1
2020
34
0.640
Why?
Digoxin
11
2021
29
0.630
Why?
Cardiovascular Diseases
11
2015
493
0.630
Why?
Prospective Studies
28
2023
2424
0.630
Why?
Diabetic Angiopathies
2
2013
23
0.620
Why?
Stroke Volume
18
2023
159
0.620
Why?
Enbucrilate
1
2019
6
0.620
Why?
Heart Ventricles
8
2012
264
0.620
Why?
Tissue Adhesives
1
2019
15
0.620
Why?
Arterial Pressure
1
2019
44
0.620
Why?
Hyperemia
3
2016
17
0.620
Why?
Pericardium
4
2022
29
0.620
Why?
Practice Guidelines as Topic
3
2020
494
0.610
Why?
Operative Time
3
2019
77
0.600
Why?
Guideline Adherence
1
2020
141
0.600
Why?
Adrenergic beta-Antagonists
5
2008
111
0.590
Why?
Aspirin
5
2022
121
0.580
Why?
Troponin T
3
2011
12
0.570
Why?
Hematoma
2
2013
67
0.570
Why?
Severity of Illness Index
19
2019
1035
0.560
Why?
Electrocardiography
15
2022
279
0.560
Why?
Heart Septum
3
2010
22
0.560
Why?
Hydrostatic Pressure
1
2017
7
0.550
Why?
Angioplasty, Balloon
4
2022
70
0.540
Why?
Perioperative Care
5
2015
42
0.540
Why?
Angiotensin-Converting Enzyme Inhibitors
10
2011
82
0.530
Why?
Creatine Kinase, MB Form
3
2013
10
0.530
Why?
Defibrillators, Implantable
5
2007
66
0.520
Why?
Surgical Procedures, Operative
4
2015
64
0.520
Why?
Foramen Ovale, Patent
2
2014
31
0.510
Why?
Purinergic P2Y Receptor Antagonists
2
2014
35
0.500
Why?
United States
27
2022
5168
0.500
Why?
Propranolol
3
2008
77
0.490
Why?
Kidney Failure, Chronic
4
2004
212
0.490
Why?
Heart
10
2006
360
0.480
Why?
Randomized Controlled Trials as Topic
12
2021
608
0.480
Why?
Veterans
1
2022
579
0.480
Why?
Tissue Donors
2
2013
124
0.470
Why?
Alloys
2
2020
9
0.470
Why?
Incidence
16
2018
1070
0.470
Why?
Heart Rupture, Post-Infarction
3
2005
5
0.460
Why?
Aortic Valve
3
2022
125
0.460
Why?
Physician-Patient Relations
2
2015
143
0.460
Why?
Fibrinolytic Agents
3
2014
131
0.450
Why?
Tomography, X-Ray Computed
5
2013
1148
0.450
Why?
Vascular System Injuries
1
2015
38
0.450
Why?
Wounds, Penetrating
1
2015
39
0.450
Why?
Ultrasonography, Interventional
7
2013
137
0.440
Why?
Purines
2
2014
33
0.430
Why?
Adenosine A2 Receptor Agonists
1
2014
5
0.430
Why?
Lisinopril
7
2003
13
0.430
Why?
Platelet Glycoprotein GPIIb-IIIa Complex
3
2009
46
0.430
Why?
Clinical Trials as Topic
9
2012
463
0.420
Why?
Anterior Wall Myocardial Infarction
2
2012
7
0.420
Why?
Computer-Assisted Instruction
1
2014
30
0.420
Why?
Metals
2
2011
37
0.420
Why?
Cyclooxygenase 2
8
2008
50
0.410
Why?
Piperazines
2
2012
125
0.410
Why?
Blood Vessel Prosthesis Implantation
4
2009
122
0.410
Why?
Pyrazoles
2
2014
113
0.410
Why?
Anticholesteremic Agents
3
2008
31
0.410
Why?
Mentors
1
2014
56
0.410
Why?
Coronary Vessel Anomalies
3
2017
37
0.410
Why?
Arteries
1
2013
93
0.400
Why?
Atrial Function, Left
1
2013
5
0.400
Why?
Endarterectomy, Carotid
2
2011
61
0.400
Why?
Lipoxins
3
2008
3
0.400
Why?
Imidazoles
9
1990
123
0.390
Why?
Cardiac Surgical Procedures
3
2014
321
0.390
Why?
Drug Administration Schedule
7
2014
374
0.390
Why?
Coronary Aneurysm
2
2007
19
0.390
Why?
Rats, Sprague-Dawley
14
2008
1534
0.390
Why?
Pressure
4
2017
102
0.390
Why?
Rats
19
2011
3146
0.380
Why?
Physicians
2
2015
235
0.380
Why?
Drug Eruptions
1
2012
14
0.380
Why?
Thiophenes
1
2012
46
0.370
Why?
Stroke
3
2013
514
0.370
Why?
Quality Assurance, Health Care
4
2012
147
0.360
Why?
Embolism
2
2013
18
0.360
Why?
Cyclooxygenase Inhibitors
5
2007
39
0.360
Why?
Double-Blind Method
14
2020
718
0.360
Why?
Internet
1
2014
260
0.360
Why?
Diverticulum
1
2011
21
0.350
Why?
Intraoperative Complications
4
2020
113
0.350
Why?
Troponin I
1
2011
19
0.350
Why?
Transurethral Resection of Prostate
1
2011
10
0.350
Why?
Carotid Arteries
1
2011
75
0.350
Why?
Receptors, Adrenergic, beta-2
2
2009
16
0.340
Why?
Embolic Protection Devices
1
2010
7
0.340
Why?
Clinical Competence
4
2013
396
0.340
Why?
Myocytes, Cardiac
5
2011
145
0.340
Why?
Receptors, Opioid, delta
2
2009
25
0.340
Why?
Paclitaxel
1
2011
90
0.340
Why?
Pericardiectomy
2
2024
6
0.330
Why?
Mitral Valve
1
2010
56
0.330
Why?
Endocarditis
1
2010
31
0.320
Why?
Kaplan-Meier Estimate
6
2017
482
0.320
Why?
Calcinosis
4
2023
52
0.310
Why?
Anticoagulants
6
2024
276
0.310
Why?
Suction
2
2008
23
0.310
Why?
Echocardiography, Transesophageal
2
2006
60
0.300
Why?
Sirolimus
2
2009
72
0.300
Why?
Adult
44
2019
14095
0.300
Why?
Hypoglycemic Agents
3
2006
217
0.290
Why?
Carotid Artery, Common
2
2006
44
0.290
Why?
Heart Valve Prosthesis
3
2022
88
0.290
Why?
Tissue Plasminogen Activator
1
2009
108
0.290
Why?
Myocardial Bridging
1
2008
2
0.290
Why?
Heart Failure, Systolic
1
2008
7
0.290
Why?
Aortic Valve Stenosis
3
2022
78
0.290
Why?
Peptides
2
2008
234
0.280
Why?
Azetidines
1
2008
6
0.280
Why?
Creatinine
3
2004
158
0.280
Why?
Patient Selection
7
2012
265
0.280
Why?
Consensus
2
2007
190
0.280
Why?
Exercise Test
10
2002
142
0.270
Why?
Heart Septal Defects, Atrial
2
2013
44
0.270
Why?
Cardiac Output, Low
4
2006
12
0.270
Why?
Animals
28
2022
13332
0.270
Why?
Telemedicine
1
2014
492
0.270
Why?
Vascular Patency
5
2020
82
0.270
Why?
Laboratories, Hospital
1
2006
6
0.260
Why?
Survival Analysis
11
2010
667
0.260
Why?
Mitral Valve Insufficiency
3
2007
55
0.260
Why?
Aortic Valve Insufficiency
2
2016
26
0.260
Why?
Terminology as Topic
3
2013
69
0.260
Why?
Echocardiography, Three-Dimensional
1
2006
15
0.250
Why?
Drug Therapy, Combination
9
2008
399
0.250
Why?
Chi-Square Distribution
3
2017
292
0.250
Why?
Pacemaker, Artificial
1
2007
42
0.250
Why?
Proportional Hazards Models
8
2017
439
0.250
Why?
Bacteremia
1
2007
89
0.240
Why?
Inpatients
2
2018
206
0.240
Why?
Gadolinium DTPA
1
2005
26
0.240
Why?
Chest Pain
3
2006
57
0.240
Why?
Nitric Oxide Synthase Type III
6
2008
82
0.230
Why?
Carotid Artery Diseases
1
2005
31
0.230
Why?
Lipopolysaccharides
1
2006
204
0.230
Why?
Calcium
1
2007
372
0.230
Why?
Angina, Stable
2
2016
7
0.230
Why?
Prostaglandins
1
2005
21
0.230
Why?
Europe
8
2019
91
0.230
Why?
Neovascularization, Physiologic
2
2005
87
0.230
Why?
Program Evaluation
1
2006
350
0.230
Why?
Pain Management
3
2015
175
0.230
Why?
Renal Insufficiency
1
2005
110
0.220
Why?
Atrial Fibrillation
4
2021
200
0.220
Why?
Dose-Response Relationship, Drug
12
2017
1368
0.220
Why?
Chemokine CCL2
1
2004
65
0.220
Why?
Metabolic Clearance Rate
1
2004
67
0.220
Why?
Plasminogen Activator Inhibitor 1
1
2004
7
0.220
Why?
Equipment Design
4
2020
290
0.220
Why?
History, 21st Century
2
2019
58
0.220
Why?
Angiography
7
2012
115
0.220
Why?
Pericardiocentesis
1
2024
16
0.210
Why?
Monocytes
1
2004
126
0.210
Why?
Femoral Artery
4
2019
107
0.210
Why?
History, 20th Century
2
2019
95
0.210
Why?
Artifacts
1
2004
54
0.210
Why?
Reoperation
5
2013
463
0.210
Why?
Staphylococcal Infections
1
2007
272
0.210
Why?
Secondary Prevention
2
2015
84
0.210
Why?
Reproducibility of Results
6
2016
1214
0.210
Why?
Arginine Vasopressin
5
2005
10
0.210
Why?
Recurrence
7
2016
680
0.210
Why?
Cardiomyopathy, Hypertrophic
1
2004
34
0.210
Why?
Disease Models, Animal
10
2011
1467
0.210
Why?
Angina Pectoris
4
2020
20
0.200
Why?
Nitric Oxide Synthase Type II
4
2008
62
0.200
Why?
Risk
7
2011
312
0.200
Why?
Aged, 80 and over
10
2017
3382
0.200
Why?
Catheterization
4
2019
95
0.200
Why?
Materials Testing
2
2020
55
0.200
Why?
American Heart Association
4
2015
33
0.190
Why?
Hospital Mortality
5
2019
451
0.190
Why?
Anti-Arrhythmia Agents
4
2004
81
0.190
Why?
Cyclosporins
5
1989
8
0.190
Why?
Body Composition
1
2004
341
0.190
Why?
Vasodilation
2
2021
101
0.190
Why?
Constriction, Pathologic
3
2017
91
0.180
Why?
Odds Ratio
4
2016
564
0.180
Why?
Exercise Tolerance
5
1997
48
0.180
Why?
Propanolamines
3
2011
14
0.180
Why?
Retreatment
2
2012
58
0.170
Why?
Diet, Sodium-Restricted
1
2000
5
0.170
Why?
Up-Regulation
4
2011
459
0.170
Why?
Enalapril
3
1989
15
0.170
Why?
Heart Valve Prosthesis Implantation
2
2016
101
0.170
Why?
United States Department of Veterans Affairs
1
2022
292
0.170
Why?
Logistic Models
5
2018
925
0.160
Why?
Hospitalization
5
2011
739
0.160
Why?
Ischemia
1
2021
154
0.160
Why?
Angioplasty
1
2020
21
0.160
Why?
Calcitonin Gene-Related Peptide
2
2009
24
0.160
Why?
Administration, Oral
8
2015
453
0.160
Why?
6-Ketoprostaglandin F1 alpha
3
2008
4
0.160
Why?
Life Style
1
2000
146
0.160
Why?
Dobutamine
5
1999
20
0.150
Why?
Plaque, Atherosclerotic
1
2019
44
0.150
Why?
Heart Rate
7
1993
317
0.150
Why?
Specialization
1
2019
49
0.150
Why?
Atherectomy
1
2019
13
0.150
Why?
Cost-Benefit Analysis
2
2014
267
0.150
Why?
Atrial Natriuretic Factor
4
1996
25
0.150
Why?
Russia
4
2019
10
0.150
Why?
Quality Improvement
2
2011
223
0.150
Why?
Radial Artery
1
2019
34
0.150
Why?
Prevalence
5
2018
1013
0.150
Why?
Feasibility Studies
2
2020
399
0.150
Why?
Peripheral Arterial Disease
1
2019
77
0.150
Why?
Proto-Oncogene Proteins c-akt
3
2009
170
0.150
Why?
Catheterization, Peripheral
1
2019
48
0.150
Why?
Patient Care Planning
1
2019
68
0.140
Why?
Tachycardia, Ventricular
2
2004
45
0.140
Why?
Cardiomyopathies
8
2003
121
0.140
Why?
Patient Care
1
1998
57
0.140
Why?
Emergency Medical Services
1
2019
112
0.140
Why?
Patient Safety
1
2018
102
0.140
Why?
Multivariate Analysis
6
2016
600
0.140
Why?
Diabetes Mellitus, Type 2
1
2004
562
0.140
Why?
Blood Pressure
12
1997
535
0.140
Why?
Medicare
2
2011
273
0.140
Why?
Fistula
2
1996
27
0.140
Why?
Education, Medical
1
2019
110
0.140
Why?
Waiting Lists
3
2007
53
0.130
Why?
Adventitia
1
2017
4
0.130
Why?
Education, Medical, Graduate
3
2013
215
0.130
Why?
Curriculum
3
2013
392
0.130
Why?
Cardiac Pacing, Artificial
3
2008
34
0.130
Why?
Quality of Life
5
2008
878
0.130
Why?
Enoximone
9
1990
10
0.130
Why?
Advisory Committees
2
2014
72
0.130
Why?
Myocardial Revascularization
3
2012
29
0.130
Why?
Hypertension, Pulmonary
7
1997
110
0.130
Why?
Substance Withdrawal Syndrome
2
1997
166
0.130
Why?
Epoprostenol
4
1997
15
0.130
Why?
Phosphorylation
6
2008
523
0.130
Why?
Nitric Oxide Synthase
2
2008
64
0.130
Why?
Simvastatin
2
2008
27
0.120
Why?
Treatment Failure
4
2018
122
0.120
Why?
Propensity Score
1
2017
157
0.120
Why?
Hypertension
6
2011
565
0.120
Why?
Health Personnel
3
2007
251
0.120
Why?
Benzazepines
2
2006
20
0.120
Why?
Phosphodiesterase Inhibitors
4
2007
23
0.120
Why?
Magnetic Resonance Imaging
1
2022
1518
0.120
Why?
Renal Insufficiency, Chronic
1
2018
201
0.120
Why?
Muscle Contraction
1
1996
116
0.120
Why?
Postpericardiotomy Syndrome
1
2015
4
0.120
Why?
Diagnostic Techniques, Cardiovascular
2
2012
4
0.120
Why?
Age Factors
5
2021
1125
0.110
Why?
Cardiomyopathy, Dilated
3
1996
37
0.110
Why?
Angioscopy
1
1994
3
0.110
Why?
Colchicine
1
2015
24
0.110
Why?
Renin
4
1996
18
0.110
Why?
Smad3 Protein
1
2014
9
0.110
Why?
Norepinephrine
5
1996
112
0.110
Why?
Systole
4
2010
74
0.110
Why?
Cholesterol, Dietary
1
2014
19
0.110
Why?
Th2 Cells
1
2014
21
0.110
Why?
Tunica Intima
1
1994
56
0.110
Why?
Cyclic AMP-Dependent Protein Kinases
3
2011
50
0.110
Why?
Patient Care Management
1
2014
18
0.110
Why?
Venous Thrombosis
1
2015
90
0.110
Why?
Myocardial Contraction
4
2009
112
0.110
Why?
Area Under Curve
3
2022
182
0.110
Why?
Receptors, LDL
1
2014
73
0.110
Why?
Disease Progression
5
2008
866
0.110
Why?
Acute Disease
5
2019
386
0.110
Why?
Punctures
3
2019
52
0.110
Why?
Cardiovascular System
1
2014
55
0.110
Why?
Thromboembolism
1
2014
49
0.110
Why?
Cohort Studies
6
2022
1541
0.110
Why?
Atherosclerosis
2
2014
225
0.110
Why?
Diuretics
4
1998
29
0.110
Why?
Dependovirus
1
2014
103
0.100
Why?
Survival Rate
6
2018
945
0.100
Why?
Transfection
1
2014
366
0.100
Why?
Cardiac Output
10
1997
41
0.100
Why?
Remote Consultation
1
2014
29
0.100
Why?
Drug Costs
1
2014
39
0.100
Why?
Quality Indicators, Health Care
2
2011
91
0.100
Why?
Arrhythmias, Cardiac
2
2012
98
0.100
Why?
Case-Control Studies
3
2013
1193
0.100
Why?
Septal Occluder Device
1
2013
36
0.100
Why?
Echocardiography, Doppler, Color
1
2013
21
0.100
Why?
Pulmonary Edema
1
2013
15
0.100
Why?
Echocardiography, Doppler
2
2016
55
0.100
Why?
Hypertrophy, Left Ventricular
3
2009
43
0.100
Why?
General Surgery
1
2014
105
0.100
Why?
Pulmonary Wedge Pressure
7
1997
23
0.100
Why?
Heparin
2
2024
87
0.100
Why?
Signal Transduction
3
2009
1699
0.100
Why?
Evidence-Based Medicine
2
2011
270
0.100
Why?
Cause of Death
7
2007
162
0.100
Why?
Pleural Effusion
1
2013
38
0.100
Why?
Ultrasonography
3
2010
420
0.100
Why?
Graft Rejection
8
2009
172
0.100
Why?
Echocardiography
7
2005
415
0.090
Why?
Kidney Diseases
2
2007
229
0.090
Why?
Image Processing, Computer-Assisted
1
2014
239
0.090
Why?
Infusions, Intravenous
7
2011
218
0.090
Why?
Embolism, Cholesterol
1
2011
2
0.090
Why?
Sex Factors
5
2022
731
0.090
Why?
Creatine Kinase
2
2003
32
0.090
Why?
Carbazoles
2
2005
18
0.090
Why?
Cardiovascular Surgical Procedures
2
2012
12
0.090
Why?
Random Allocation
4
2005
289
0.090
Why?
Equipment Failure
3
2008
64
0.090
Why?
Exercise
1
1996
552
0.090
Why?
Milrinone
1
2011
7
0.090
Why?
Isoenzymes
2
2003
166
0.090
Why?
Insurance Claim Review
1
2011
39
0.090
Why?
Death
2
2022
23
0.090
Why?
Diabetes Complications
3
2011
124
0.090
Why?
Enkephalin, D-Penicillamine (2,5)-
2
2009
3
0.090
Why?
Unnecessary Procedures
1
2011
20
0.090
Why?
Prednisone
3
1989
102
0.090
Why?
Oxygen Consumption
5
1996
200
0.080
Why?
Body Weight
3
2007
526
0.080
Why?
Preoperative Care
2
2007
174
0.080
Why?
Thrombectomy
1
2011
73
0.080
Why?
Necrosis
1
2010
169
0.080
Why?
Injections, Intra-Arterial
2
2015
13
0.080
Why?
Cyclooxygenase 2 Inhibitors
2
2007
22
0.080
Why?
Texas
4
2006
140
0.080
Why?
Disease Management
3
2014
185
0.080
Why?
Surgical Instruments
1
2010
28
0.080
Why?
Cells, Cultured
4
2009
1568
0.080
Why?
Reperfusion Injury
2
2007
71
0.080
Why?
Magnetic Resonance Imaging, Cine
1
2010
63
0.080
Why?
Diatrizoate
1
1989
2
0.080
Why?
Iopamidol
1
1989
2
0.080
Why?
Receptors, Calcitonin Gene-Related Peptide
1
2009
4
0.080
Why?
Ethanolamines
2
1986
10
0.080
Why?
ROC Curve
2
2022
250
0.080
Why?
Hyperlipidemias
2
2011
52
0.080
Why?
Endothelium, Vascular
2
2007
257
0.070
Why?
Drug Administration Routes
1
2008
10
0.070
Why?
Leukotriene B4
1
2008
1
0.070
Why?
Arachidonate 5-Lipoxygenase
1
2008
3
0.070
Why?
Fatal Outcome
2
2007
192
0.070
Why?
Hemostasis, Surgical
1
2008
12
0.070
Why?
Phospholipases A
2
2006
14
0.070
Why?
Phospholipases A2
2
2006
15
0.070
Why?
Comorbidity
1
2010
628
0.070
Why?
Patient Transfer
1
2009
99
0.070
Why?
Meta-Analysis as Topic
1
2008
39
0.070
Why?
Analysis of Variance
2
2008
554
0.070
Why?
Drainage
1
2008
87
0.070
Why?
Kidney
3
2005
713
0.070
Why?
Sulfonamides
2
2008
132
0.070
Why?
Heart Diseases
3
2006
220
0.070
Why?
Myocardial Reperfusion
1
2007
13
0.070
Why?
Combined Modality Therapy
1
2009
634
0.070
Why?
Mitogen-Activated Protein Kinase 3
1
2007
49
0.070
Why?
Tetrazoles
1
2007
41
0.070
Why?
Dipyridamole
1
2007
7
0.070
Why?
Prosthesis Failure
2
2012
112
0.070
Why?
Microinjections
2
2018
35
0.070
Why?
Prostaglandin D2
1
2007
21
0.070
Why?
Cyclooxygenase 1
1
2007
7
0.070
Why?
Drug Interactions
2
2007
201
0.070
Why?
Calcium Signaling
1
2007
52
0.070
Why?
Nitroso Compounds
1
2006
3
0.070
Why?
Patient Admission
1
2007
80
0.060
Why?
Thoracic Surgery
1
2007
22
0.060
Why?
Mass Screening
2
2004
356
0.060
Why?
Enzyme Induction
1
2006
76
0.060
Why?
Anemia, Macrocytic
1
1986
2
0.060
Why?
Deferoxamine
1
1986
9
0.060
Why?
Anemia, Megaloblastic
1
1986
3
0.060
Why?
PPAR gamma
1
2007
72
0.060
Why?
Biotin
1
2006
46
0.060
Why?
Ubiquinone
1
2006
14
0.060
Why?
NF-kappa B
1
2008
329
0.060
Why?
Hemofiltration
1
2006
8
0.060
Why?
Diagnosis, Differential
2
2012
1031
0.060
Why?
Magnesium
1
2006
32
0.060
Why?
Electric Countershock
1
2006
30
0.060
Why?
Forecasting
1
2007
152
0.060
Why?
Patient Education as Topic
2
2000
318
0.060
Why?
Multicenter Studies as Topic
4
2005
112
0.060
Why?
Intracranial Embolism
1
2006
29
0.060
Why?
Radiology
1
2008
133
0.060
Why?
Antihypertensive Agents
2
1997
131
0.060
Why?
Heart Atria
1
2006
64
0.060
Why?
Ischemic Preconditioning
1
2005
5
0.060
Why?
Aortic Rupture
1
2006
18
0.060
Why?
Triiodobenzoic Acids
1
2005
9
0.060
Why?
Partnership Practice
1
2005
1
0.060
Why?
Organizational Affiliation
1
2005
2
0.060
Why?
Myocardial Stunning
1
2005
2
0.060
Why?
Health Planning
1
2005
13
0.060
Why?
Pyrrolidines
1
2006
63
0.060
Why?
Metoprolol
1
2005
13
0.060
Why?
Foreign Bodies
1
2006
66
0.060
Why?
Device Removal
1
2006
82
0.060
Why?
Anti-Inflammatory Agents, Non-Steroidal
1
2006
123
0.060
Why?
Gastrointestinal Hemorrhage
1
2006
91
0.060
Why?
Iron
1
1986
130
0.060
Why?
Aortic Coarctation
1
2006
31
0.060
Why?
Sensitivity and Specificity
3
2006
871
0.060
Why?
Accidents, Traffic
1
2006
90
0.060
Why?
Isoxazoles
1
2005
15
0.060
Why?
Intramolecular Oxidoreductases
1
2005
11
0.060
Why?
Prostaglandin-Endoperoxide Synthases
1
2005
25
0.060
Why?
Education, Medical, Continuing
1
2005
72
0.060
Why?
Water-Electrolyte Balance
1
1985
30
0.060
Why?
Tetralogy of Fallot
1
2006
83
0.060
Why?
Ephedrine
1
2004
21
0.060
Why?
Leadership
1
2005
104
0.060
Why?
Regional Blood Flow
1
2004
110
0.060
Why?
Membrane Proteins
1
2007
328
0.060
Why?
Hyperhomocysteinemia
1
2004
29
0.060
Why?
Body Surface Area
1
2004
27
0.060
Why?
Polyethylene Terephthalates
1
2004
10
0.050
Why?
Brachiocephalic Trunk
1
2004
6
0.050
Why?
Antioxidants
1
2006
257
0.050
Why?
Ventricular Remodeling
1
2004
65
0.050
Why?
Pregnancy Complications, Cardiovascular
1
2004
37
0.050
Why?
Abnormalities, Multiple
1
2006
168
0.050
Why?
Injections, Intravenous
4
2004
133
0.050
Why?
Vascular Endothelial Growth Factor A
1
2005
187
0.050
Why?
Arteriosclerosis
1
2004
50
0.050
Why?
Swine Diseases
1
2004
7
0.050
Why?
Potassium Channels
1
2004
31
0.050
Why?
Inflammation
2
2007
641
0.050
Why?
Myocarditis
1
1984
48
0.050
Why?
Enoxaparin
1
2024
31
0.050
Why?
ATP-Binding Cassette Transporters
1
2004
35
0.050
Why?
Edema
1
2004
64
0.050
Why?
Cytochrome P-450 Enzyme System
1
2005
191
0.050
Why?
Staphylococcus aureus
1
2007
312
0.050
Why?
Vasoconstrictor Agents
1
2004
80
0.050
Why?
Immunohistochemistry
2
2005
975
0.050
Why?
Radiography
3
2006
472
0.050
Why?
Glomerular Filtration Rate
2
2018
127
0.050
Why?
Sample Size
1
2003
49
0.050
Why?
Heart Aneurysm
1
1983
13
0.050
Why?
Retroperitoneal Space
1
2002
25
0.050
Why?
Internship and Residency
1
2008
433
0.050
Why?
C-Reactive Protein
1
2003
152
0.050
Why?
Methoxamine
2
1993
4
0.050
Why?
Mitral Valve Prolapse
1
1982
4
0.050
Why?
Drug Synergism
3
2007
148
0.050
Why?
Morphine Derivatives
1
2022
27
0.050
Why?
Anesthesia
1
2002
65
0.050
Why?
Renal Dialysis
1
2003
190
0.050
Why?
Pain Clinics
1
2001
3
0.040
Why?
Hospital Units
1
2001
11
0.040
Why?
Hospitals
1
2022
180
0.040
Why?
Dogs
3
1993
182
0.040
Why?
Benchmarking
2
2011
64
0.040
Why?
Heart Arrest
1
2002
135
0.040
Why?
Nitroglycerin
3
2004
8
0.040
Why?
Comprehensive Health Care
1
2000
9
0.040
Why?
Fluoroscopy
2
1993
51
0.040
Why?
Autopsy
1
2000
47
0.040
Why?
Cardiology Service, Hospital
1
2000
15
0.040
Why?
Arkansas
2
2016
2016
0.040
Why?
Tissue Scaffolds
1
2020
40
0.040
Why?
Vitamins
1
2000
65
0.040
Why?
Biocompatible Materials
1
2020
65
0.040
Why?
Amyloidosis
2
1991
85
0.040
Why?
Public Policy
2
2012
38
0.040
Why?
Anti-Inflammatory Agents
2
2015
166
0.040
Why?
Diastole
2
1993
68
0.040
Why?
Peripheral Vascular Diseases
1
2000
23
0.040
Why?
Oxidative Stress
1
2004
809
0.040
Why?
Renal Artery Obstruction
1
2000
21
0.040
Why?
Disease-Free Survival
1
2000
462
0.040
Why?
Hospitals, Public
1
1999
7
0.040
Why?
Placebos
2
1990
85
0.040
Why?
Carotid Stenosis
1
2000
64
0.040
Why?
Syndrome
3
2006
247
0.040
Why?
Morbidity
1
1999
140
0.040
Why?
Risk Adjustment
1
2019
17
0.040
Why?
Adolescent
7
1996
6681
0.040
Why?
Mice, Knockout
2
2014
893
0.040
Why?
Quality of Health Care
1
2000
187
0.040
Why?
Injections, Intralesional
1
2018
32
0.040
Why?
Internationality
1
2018
46
0.040
Why?
Patient Care Team
1
2000
271
0.040
Why?
Radiation Dosage
1
2019
160
0.040
Why?
Drug Evaluation
2
1995
25
0.040
Why?
Ventricular Pressure
1
1997
16
0.030
Why?
Administration, Intravenous
1
2018
73
0.030
Why?
Immunoblotting
2
2008
118
0.030
Why?
Health Services Needs and Demand
1
1999
159
0.030
Why?
Respiration
2
1996
100
0.030
Why?
Internal Mammary-Coronary Artery Anastomosis
1
1997
6
0.030
Why?
Calcium Channel Blockers
1
1997
60
0.030
Why?
Radiation Monitoring
1
2017
7
0.030
Why?
Biopsy
5
1994
599
0.030
Why?
International Cooperation
2
2007
52
0.030
Why?
Enzyme-Linked Immunosorbent Assay
2
2008
234
0.030
Why?
Cardiomegaly
2
1988
57
0.030
Why?
Patient Compliance
1
1998
229
0.030
Why?
Ventricular Function, Right
1
1997
40
0.030
Why?
Hormones
2
1987
59
0.030
Why?
Isotonic Contraction
1
1996
1
0.030
Why?
Isometric Contraction
1
1996
21
0.030
Why?
Vascular Resistance
3
1997
50
0.030
Why?
Forearm
1
1996
31
0.030
Why?
Mice
3
2014
5877
0.030
Why?
Socioeconomic Factors
1
1998
603
0.030
Why?
Data Collection
3
2011
286
0.030
Why?
Italy
1
2015
26
0.030
Why?
Delivery of Health Care
1
1998
318
0.030
Why?
Carbon Dioxide
1
1996
96
0.030
Why?
Blood Flow Velocity
1
2015
95
0.030
Why?
Phlebography
1
2015
55
0.030
Why?
Neurotransmitter Agents
1
1995
33
0.030
Why?
Radionuclide Angiography
1
1994
1
0.030
Why?
Tubulin Modulators
1
2015
28
0.030
Why?
Atherectomy, Coronary
1
1994
6
0.030
Why?
Cross-Sectional Studies
1
2020
1665
0.030
Why?
Time
1
2014
29
0.030
Why?
Journal Impact Factor
1
2014
8
0.030
Why?
Kinetics
2
1986
616
0.030
Why?
Genetic Vectors
1
2014
128
0.030
Why?
Models, Cardiovascular
2
2004
22
0.030
Why?
Nervous System Diseases
1
1995
94
0.030
Why?
Fibrosis
1
2014
197
0.030
Why?
Pulmonary Circulation
1
1993
28
0.030
Why?
Monitoring, Physiologic
1
2014
122
0.030
Why?
Learning Curve
1
2013
19
0.030
Why?
Drug Monitoring
1
1993
82
0.030
Why?
Ultrasonics
1
1993
26
0.030
Why?
Apoptosis
2
2011
1117
0.030
Why?
Ischemic Attack, Transient
1
2013
59
0.030
Why?
Jugular Veins
1
1993
29
0.030
Why?
Cardiac Imaging Techniques
1
2012
8
0.020
Why?
Gene Expression Regulation
2
2008
1000
0.020
Why?
Alprostadil
1
1992
10
0.020
Why?
Mice, Inbred C57BL
2
2008
1872
0.020
Why?
Intra-Aortic Balloon Pumping
1
1992
7
0.020
Why?
Tissue Survival
1
2012
10
0.020
Why?
Smoking
2
2011
516
0.020
Why?
Myocardial Perfusion Imaging
1
2012
17
0.020
Why?
Obesity
1
2000
1183
0.020
Why?
Endocardium
2
1989
6
0.020
Why?
Tomography, Emission-Computed, Single-Photon
1
2012
52
0.020
Why?
Phosphodiesterase 3 Inhibitors
1
2011
1
0.020
Why?
Health Status
1
1993
300
0.020
Why?
Adrenergic beta-1 Receptor Antagonists
1
2011
7
0.020
Why?
Health Policy
1
2012
160
0.020
Why?
In Situ Nick-End Labeling
1
2011
54
0.020
Why?
Adrenergic beta-Agonists
1
1991
42
0.020
Why?
Goals
1
1991
45
0.020
Why?
Diagnostic Imaging
1
2012
172
0.020
Why?
Recovery of Function
1
2012
201
0.020
Why?
Critical Care
1
2012
214
0.020
Why?
Mannitol
1
1990
15
0.020
Why?
Dopamine
1
1991
169
0.020
Why?
Body Water
1
1990
27
0.020
Why?
Vasoconstriction
1
1990
56
0.020
Why?
Blood Volume
1
1990
63
0.020
Why?
Sodium
1
1990
90
0.020
Why?
Graft Survival
1
1991
158
0.020
Why?
Program Development
1
2011
164
0.020
Why?
Adrenergic beta-2 Receptor Antagonists
1
2009
1
0.020
Why?
Adrenergic beta-2 Receptor Agonists
1
2009
5
0.020
Why?
Transplantation, Homologous
1
2009
149
0.020
Why?
Lymphocytes
1
1990
146
0.020
Why?
Cell Death
1
2009
169
0.020
Why?
Isoquinolines
1
2008
21
0.020
Why?
Serine
1
2008
35
0.020
Why?
Tyrphostins
1
2008
10
0.020
Why?
Janus Kinases
1
2008
7
0.020
Why?
Physical Exertion
1
1988
46
0.020
Why?
Electrophoretic Mobility Shift Assay
1
2008
71
0.020
Why?
Selection Bias
1
2008
15
0.020
Why?
Pulse
1
1988
13
0.020
Why?
Pennsylvania
3
1993
34
0.020
Why?
Ischemic Preconditioning, Myocardial
1
2007
2
0.020
Why?
Enzyme Activation
1
2008
269
0.020
Why?
Organ Culture Techniques
1
2007
44
0.020
Why?
Creatine Kinase, BB Form
1
2007
1
0.020
Why?
Bayes Theorem
1
1988
120
0.020
Why?
Receptors, Purinergic P1
1
2007
7
0.020
Why?
Survival
1
2007
12
0.020
Why?
Immunologic Factors
1
2008
117
0.020
Why?
Theophylline
1
2007
18
0.020
Why?
Pyridazines
1
1987
10
0.020
Why?
5'-Nucleotidase
1
2007
12
0.020
Why?
Pain
2
1982
353
0.020
Why?
Nitriles
1
2007
51
0.020
Why?
Blood Coagulation
1
2007
60
0.020
Why?
Bundle-Branch Block
1
1987
19
0.020
Why?
Models, Chemical
1
2007
66
0.020
Why?
Premedication
1
2007
17
0.020
Why?
Evaluation Studies as Topic
3
1992
105
0.020
Why?
Butadienes
1
2007
49
0.020
Why?
Drug Combinations
1
2007
134
0.020
Why?
Depression, Chemical
1
1986
13
0.020
Why?
Coenzymes
1
2006
3
0.020
Why?
Stimulation, Chemical
1
1986
27
0.020
Why?
Vasoactive Intestinal Peptide
1
1986
20
0.020
Why?
Amrinone
1
1986
1
0.020
Why?
Heart Function Tests
1
1986
11
0.020
Why?
Oncogene Protein v-akt
1
2006
12
0.020
Why?
Fluid Therapy
1
2007
79
0.020
Why?
Educational Measurement
1
2008
194
0.020
Why?
Receptors, Vasopressin
1
2006
23
0.020
Why?
Phosphoric Monoester Hydrolases
1
2006
23
0.020
Why?
Alanine
1
2006
43
0.020
Why?
Amidines
1
2006
6
0.020
Why?
Lactates
1
1986
31
0.020
Why?
Protein Kinase Inhibitors
1
2008
225
0.020
Why?
Benzylamines
1
2006
14
0.020
Why?
Sulfones
1
2006
24
0.020
Why?
PTEN Phosphohydrolase
1
2006
55
0.020
Why?
Long-Term Care
1
1986
51
0.020
Why?
Models, Animal
1
2006
228
0.010
Why?
Research Design
1
2008
367
0.010
Why?
Nitric Oxide
1
2007
234
0.010
Why?
Magnetic Resonance Angiography
1
2006
67
0.010
Why?
Heart Conduction System
1
2005
25
0.010
Why?
Osmotic Pressure
1
1985
11
0.010
Why?
Half-Life
1
1985
87
0.010
Why?
Safety
1
2005
80
0.010
Why?
Diabetes Mellitus
1
1989
316
0.010
Why?
Osmolar Concentration
1
1985
62
0.010
Why?
Enzyme Inhibitors
1
2007
371
0.010
Why?
Aortography
1
2004
33
0.010
Why?
Glyburide
1
2004
5
0.010
Why?
Anastomosis, Surgical
1
2004
69
0.010
Why?
Scleroderma, Systemic
1
1984
6
0.010
Why?
Ventricular Fibrillation
1
2004
17
0.010
Why?
Anesthesia, Obstetrical
1
2004
39
0.010
Why?
Verapamil
1
1984
20
0.010
Why?
Models, Biological
1
2007
731
0.010
Why?
Vascular Surgical Procedures
1
2006
166
0.010
Why?
Statistics as Topic
1
2004
89
0.010
Why?
Patient Discharge
1
2006
322
0.010
Why?
Transcription Factors
1
2007
564
0.010
Why?
NG-Nitroarginine Methyl Ester
1
2003
11
0.010
Why?
Cesarean Section
1
2004
183
0.010
Why?
Pulmonary Artery
1
1984
146
0.010
Why?
Swine
1
2004
426
0.010
Why?
Endpoint Determination
1
2002
27
0.010
Why?
Thorax
1
1982
14
0.010
Why?
Anxiety Disorders
1
1982
130
0.010
Why?
Popliteal Artery
1
2000
28
0.010
Why?
Iliac Artery
1
2000
31
0.010
Why?
Hospitals, University
1
1999
74
0.010
Why?
Mortality
1
1999
104
0.010
Why?
Brain
1
2006
1311
0.010
Why?
Abdomen
1
1977
73
0.010
Why?
Dyspnea
1
1977
79
0.010
Why?
Pregnancy
1
2004
2658
0.010
Why?
Physical Examination
1
1977
98
0.010
Why?
Fatigue
1
1977
129
0.010
Why?
Physical Fitness
1
1997
57
0.010
Why?
Actuarial Analysis
1
1996
9
0.010
Why?
Walking
1
1997
106
0.010
Why?
Nitroprusside
1
1992
11
0.010
Why?
Neck
1
1993
98
0.010
Why?
Pilot Projects
1
1995
712
0.010
Why?
Transplantation, Heterotopic
1
1991
7
0.010
Why?
Regression Analysis
1
1991
399
0.010
Why?
Cyclosporine
1
1991
67
0.010
Why?
Cytotoxicity, Immunologic
1
1990
56
0.010
Why?
Histocompatibility Testing
1
1990
14
0.010
Why?
Transplantation, Heterologous
1
1989
78
0.000
Why?
Cell Division
1
1990
288
0.000
Why?
Length of Stay
1
1991
666
0.000
Why?
Bundle of His
1
1987
7
0.000
Why?
Atrial Flutter
1
1987
9
0.000
Why?
Phenotype
1
1990
794
0.000
Why?
Cobalt
1
1986
17
0.000
Why?
Histological Techniques
1
1986
9
0.000
Why?
Endomyocardial Fibrosis
1
1985
3
0.000
Why?
Doxorubicin
1
1986
242
0.000
Why?
Thallium
1
1984
6
0.000
Why?
Radioisotopes
1
1984
17
0.000
Why?
Heart Defects, Congenital
1
1990
611
0.000
Why?
Microcirculation
1
1984
63
0.000
Why?
Radionuclide Imaging
1
1984
104
0.000
Why?
Infant
1
1990
3660
0.000
Why?
Child, Preschool
1
1990
4001
0.000
Why?
Child
1
1990
7147
0.000
Why?
Uretsky's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description